Microneedles: A Modern Breakthrough in Drug Delivery Systems

Year : 2025 | Volume : 12 | Issue : 03 | Page : 01 07
    By

    Ujjawal Tamboli,

  • Pankaj Chasta,

  • Chhaya Deval,

  • Shivam Rongpi,

  • Kamalesh Mistry,

  1. Research Scholar, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  2. Associate Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  3. Manufacturing Chemist, Malook Pharmaceutical Pvt. Ltd., South Delhi, India
  4. Assistant Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India
  5. Assistant Professor, Department of Pharmacy, Faculty of Pharmaceutical Science, Mewar University, Gangrar, Chittorgarh, Rajasthan, India

Abstract

Microneedles (MNs) represent a revolutionary and transformative advancement in the realm of transdermal drug delivery systems, which are designed to facilitate the administration of therapeutic agents through the skin. These exceptionally small, micron-scale needles penetrate the stratum corneum, thereby enabling the direct delivery of pharmacological agents into the underlying dermis or the upper epidermis, consequently enhancing bioavailability while simultaneously circumventing the detrimental effects of first-pass metabolism and the degradation that often occurs within the digestive system. Fabricated from a variety of materials including, but not limited to, metals, polymers, silicon, and various sugars, microneedles are produced through cutting-edge manufacturing processes such as photolithography, micromolding, and advanced 3D printing techniques, and they can be classified into several categories including solid, coated, dissolving, hollow, and hydrogel-forming. They have exhibited remarkable potential across a wide array of applications, including cosmetic enhancements, diagnostic purposes, oncological treatments, vaccination strategies, and innovative drug delivery systems. Despite the numerous advantages that microneedles offer, such as enhanced patient compliance and the convenience of self-administration, there remain significant challenges that must be addressed, including issues related to mechanical strength, inadequate drug loading capabilities, and various regulatory hurdles that could impede their widespread adoption. The ongoing research focused on the development of intelligent microneedles and personalized therapeutic approaches underscores the pivotal role that microneedles are poised to play as an essential innovation in the future landscape of healthcare solutions.

Keywords: Microneedles, Transdermal Drug Delivery, Minimally Invasive Systems, Controlled Release Technology, Pharmaceutical Microfabrication.

[This article belongs to Trends in Drug Delivery ]

How to cite this article:
Ujjawal Tamboli, Pankaj Chasta, Chhaya Deval, Shivam Rongpi, Kamalesh Mistry. Microneedles: A Modern Breakthrough in Drug Delivery Systems. Trends in Drug Delivery. 2025; 12(03):01-07.
How to cite this URL:
Ujjawal Tamboli, Pankaj Chasta, Chhaya Deval, Shivam Rongpi, Kamalesh Mistry. Microneedles: A Modern Breakthrough in Drug Delivery Systems. Trends in Drug Delivery. 2025; 12(03):01-07. Available from: https://journals.stmjournals.com/tdd/article=2025/view=229150


References

  1. Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev. 2006;58(1):68–89. doi:10.1016/j.addr.2005.12.003
  2. Nir Y, Paz A, Sabo E, Potasman I. Fear of injections in young adults: prevalence and associations. Am J Trop Med Hyg. 2003;68(3):341–344. doi:10.4269/ajtmh.2003.68.341
  3. Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract. 1995;41(2):169–175. https://pubmed.ncbi.nlm.nih.gov/7636457/
  4. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358(9297):1989–1992. doi:10.1016/S0140-6736(01)06967-7
  5. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004;19(1):95–103. doi:10.1093/heapro/dah110
  6. Singh R, Singh S, Lillard JW Jr. Past, present, and future technologies for oral delivery of therapeutic proteins. J Pharm Sci. 2008;97(7):2497–2523. doi:10.1002/jps.21183
  7. Amorij JP, Hinrichs WLJ, Frijlink HW, Wilschut JC, Huckriede A. Needle-free influenza vaccination. Lancet Infect Dis. 2010;10(10):699–711. doi:10.1016/S1473-3099(10)70157-2
  8. Mitragotri S. Immunization without needles. Nat Rev Immunol. 2005;5(12):905–916. doi:10.1038/nri1728
  9. Bronaugh RL, Maibach HI, editors. Percutaneous absorption: Drugs–Cosmetics–Mechanisms–Methodology. New York: Marcel Dekker; 2005.
  10. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369–393. doi:10.1007/978-3-540-92165-3_18
  11. Patel SR, Edelhauser HF, Prausnitz MR. Targeted drug delivery to the eye enabled by microneedles. In: Kompella UB, Edelhauser HF, editors. Drug product development for the back of the eye. Arlington (VA): AAPS; 2011. p.331–360.
  12. Yum K, Yu MF, Wang N, Xiang YK. Biofunctionalized nanoneedles for the direct and site-selective delivery of probes into living cells. Biochim Biophys Acta. 2011;1810(3):330–338. doi:10.1016/j.bbagen.2010.05.005
  13. Yum K, Wang N, Yu MF. Nanoneedle: a multifunctional tool for biological studies in living cells. Nanoscale. 2010;2(3):363–372. doi:10.1039/b9nr00231f
  14. Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm. 2008;364(2):227–236. doi:10.1016/j.ijpharm.2008.08.032
  15. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv. 2009;6(4):343–354. doi:10.1517/17425240902841935
  16. Birchall JC. Microneedle array technology: the time is right but is the science ready? Expert Rev Med Devic. 2006;3(1):1–4. doi:10.1586/17434440.3.1.1
  17. Coulman S, Allender CJ, Birchall JC. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst. 2006;23(3):205–258. doi:10.1615/critrevtherdrugcarriersyst.v23.i3.20
  18. Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010;17(4):187–207. doi:10.3109/10717541003667798
  19. Garland MJ, Migalska K, Mazela T, Mahmood T, Raghu T, Singh R, Woolfson AD, Donnelly RF. Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devic. 2011;8(4):459–482. doi:10.1586/erd.11.20
  20. Gittard SD, Ovsianikov A, Chichkov BN, Doraiswamy A, Narayan RJ. Two-photon polymerization of microneedles for transdermal drug delivery. Expert Opin Drug Deliv. 2010;7(4):513–533. doi:10.1517/17425241003628171
  21. Kalluri H, Banga AK. Microneedles and transdermal drug delivery. J Drug Deliv Sci Technol. 2009;19(5):303–310. doi:10.1016/S1773-2247(09)50065-2
  22. Khanna P, Strom JA, Malone JI, Bhansali S. Microneedle-based automated therapy for diabetes mellitus. J Diabetes Sci Technol. 2008;2(6):1122–1129. doi:10.1177/193229680800200621
  23. McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng. 2000;2:289–313. doi:10.1146/annurev.bioeng.2.1.289
  24. Milewski M, Brogden NK, Stinchcomb AL. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv. 2010;7(5):617–629. doi:10.1517/17425241003663228
  25. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56(5):581–587. doi:10.1016/j.addr.2003.10.023
  26. Reed ML, Lye WK. Microsystems for drug and gene delivery. Proc IEEE. 2004;92(1):56–75. doi:10.1109/JPROC.2003.820542
  27. Sachdeva V, Banga AK. Microneedles and their applications. Recent Pat Drug Deliv Formul. 2011;5(2):95–132. doi:10.2174/187221111795471445
  28. Shah UU, Roberts M, Orlu-Gul M, Tuleu C, Beresford MW. Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int J Pharm. 2011;416(1):1–11. doi:10.1016/j.ijpharm.2011.07.002
  29. Singh TRR, Dunne NJ, Cunningham E, Donnelly RF. Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul. 2011;5(1):11–23. doi:10.2174/187221111794109484
  30. Singh TRR, Garland MJ, Cassidy CM, Migalska K, Demir YK, Abdelghany S, Ryan E, Woolfson AD, Donnelly RF. Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul. 2010;4(1):1–17. doi:10.2174/187221110789957174
  31. Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Expert Opin Drug Deliv. 2007;4(1):19–25. doi:10.1517/17425247.4.1.19
  32. Vandervoort J, Ludwig A. Microneedles for transdermal drug delivery: a minireview. Front Biosci. 2008;13:1711–1715. doi:10.2741/2794
  33. Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11–29. doi:10.1111/j.2042-7158.2011.01369.x
  34. Park HA, Roy S, Khanna S, Sen CK. Current technologies in single-cell microinjection and application to study signal transduction. In: Das DK, editor. Methods in Redox Signaling. New Rochelle (NY): Mary Ann Liebert; 2010. p.71–77.
  35. Gerstel MS, Place VA. Drug delivery device. U.S. Patent 3,964,482. 1976.
  36. Madou MJ. Fundamentals of microfabrication and nanotechnology. Boca Raton (FL): CRC Press; 2011.
  37. Williams A. Transdermal and topical drug delivery. London: Pharmaceutical Press; 2011.
  38. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, Prausnitz MR. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100(24):13755–13760. doi:10.1073/pnas.2331316100
  39. Wilke N, Mulcahy A, Ye SR, Morrissey A. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectron J. 2005;36(6):650–656. doi:10.1016/j.mejo.2005.04.044
Regular Issue Subscription Review Article
Volume 12
Issue 03
Received 16/06/2025
Accepted 21/06/2025
Published 11/10/2025
Publication Time 117 Days
162

Login


My IP

PlumX Metrics